These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7854179)

  • 1. Relationships of human immunodeficiency virus protease with eukaryotic aspartic proteases.
    Lin XL; Lin YZ; Tang J
    Methods Enzymol; 1994; 241():195-224. PubMed ID: 7854179
    [No Abstract]   [Full Text] [Related]  

  • 2. A new way of looking at aspartic proteinase structures: a comparison of pepsin structure to other aspartic proteinases in the near active site region.
    Andreeva NS; Bochkarev A; Pechik I
    Adv Exp Med Biol; 1995; 362():19-32. PubMed ID: 8540318
    [No Abstract]   [Full Text] [Related]  

  • 3. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
    Ringe D
    Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG; Heinrikson RL
    Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
    [No Abstract]   [Full Text] [Related]  

  • 5. Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis.
    Culberson JC; Bush BL; Sardana VV
    Methods Enzymol; 1994; 241():385-94. PubMed ID: 7854190
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular modeling of the structure of FIV protease.
    Gustchina A
    Adv Exp Med Biol; 1995; 362():479-84. PubMed ID: 8540361
    [No Abstract]   [Full Text] [Related]  

  • 7. Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis.
    Kent SB; Baca M; Elder J; Miller M; Milton R; Milton S; Rao JK; Schnölzer M
    Adv Exp Med Biol; 1995; 362():425-38. PubMed ID: 8540353
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzymic activities of two-chain pepsinogen, two-chain pepsin, and the amino-terminal lobe of pepsinogen.
    Lin XL; Lin YZ; Koelsch G; Gustchina A; Wlodawer A; Tang J
    J Biol Chem; 1992 Aug; 267(24):17257-63. PubMed ID: 1512263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases.
    Rao JK; Erickson JW; Wlodawer A
    Biochemistry; 1991 May; 30(19):4663-71. PubMed ID: 1851433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ddi1, a eukaryotic protein with the retroviral protease fold.
    Sirkis R; Gerst JE; Fass D
    J Mol Biol; 2006 Dec; 364(3):376-87. PubMed ID: 17010377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of dimeric retroviral proteases.
    Darke PL
    Methods Enzymol; 1994; 241():104-27. PubMed ID: 7854174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of the HIV-2 protease.
    Gustchina A; Weber IT; Wlodawer A
    Adv Exp Med Biol; 1991; 306():549-53. PubMed ID: 1812757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Retroviral proteases 20 years later: reminiscences].
    Jaskólski M
    Postepy Biochem; 2009; 55(1):15-20. PubMed ID: 19514461
    [No Abstract]   [Full Text] [Related]  

  • 15. Activities of precursor and tethered dimer forms of HIV proteinase.
    Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
    Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
    Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
    Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolutionarily conserved functional mechanics across pepsin-like and retroviral aspartic proteases.
    Cascella M; Micheletti C; Rothlisberger U; Carloni P
    J Am Chem Soc; 2005 Mar; 127(11):3734-42. PubMed ID: 15771507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the sequences, 3-D structures and mechanisms of pepsin-like and retroviral aspartic proteinases.
    Blundell TL; Cooper JB; Sali A; Zhu ZY
    Adv Exp Med Biol; 1991; 306():443-53. PubMed ID: 1812741
    [No Abstract]   [Full Text] [Related]  

  • 19. Computer simulation and analysis of the reaction pathway for the decomposition of the hydrated peptide bond in aspartic proteases.
    Cachau RE; Topol IA; Burt SK; Silva AM; Erickson JW
    Adv Exp Med Biol; 1995; 362():461-5. PubMed ID: 8540358
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.